4//SEC Filing
QUAY STEVEN C 4
Accession 0000950170-24-079559
CIK 0001488039other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:00 PM ET
Size
5.5 KB
Accession
0000950170-24-079559
Insider Transaction Report
Form 4
QUAY STEVEN C
DirectorCEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-06-27+1,795,100→ 1,795,100 totalExercise: $1.05Exp: 2034-06-27→ Common Stock (1,795,100 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 24 months following June 27, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued at approximately 9:30 a.m. (ET) on June 27, 2024, with an exercise price of $1.05, representing the most recently reported closing stock price on June 26, 2024.
Documents
Issuer
ATOSSA THERAPEUTICS, INC.
CIK 0001488039
Entity typeother
Related Parties
1- filerCIK 0001008227
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:00 PM ET
- Size
- 5.5 KB